Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Sana Biotechnology Inc’s stock clocked out at $3.46, up 1.76% from its previous closing price of $3.4. In other words, the price has increased by $1.76 from its previous closing price. On the day, 4.56 million shares were traded. SANA stock price reached its highest trading level at $3.49 during the session, while it also had its lowest trading level at $3.24.
Ratios:
To gain a deeper understanding of SANA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.58.
On March 18, 2025, Citizens JMP Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $5.
On March 14, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $7.Jefferies initiated its Buy rating on March 14, 2025, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares for $3.16 per share.
CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares of SANA for $289,500 on Jan 16 ’25. On Jan 08 ’25, another insider, FMR LLC, who serves as The insider 1 of the company, sold 290,912 shares for $6.49 each. As a result, the insider received 1,887,320 and left with 4,541,511 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 878466304 and an Enterprise Value of 835628480.
Stock Price History:
The Beta on a monthly basis for SANA is 1.90, which has changed by -0.34716982 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, SANA has reached a high of $7.30, while it has fallen to a 52-week low of $1.26. The 50-Day Moving Average of the stock is -3.38%, while the 200-Day Moving Average is calculated to be 28.24%.
Shares Statistics:
It appears that SANA traded 5.65M shares on average per day over the past three months and 8193440 shares per day over the past ten days. A total of 230.51M shares are outstanding, with a floating share count of 132.87M. Insiders hold about 44.13% of the company’s shares, while institutions hold 48.21% stake in the company. Shares short for SANA as of 1753920000 were 30778592 with a Short Ratio of 5.45, compared to 1751241600 on 37530428. Therefore, it implies a Short% of Shares Outstanding of 30778592 and a Short% of Float of 54.11.
Earnings Estimates
The market rating for Sana Biotechnology Inc (SANA) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.14 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.66 and -$0.84 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.64, with 3.0 analysts recommending between -$0.63 and -$0.66.
